Global Vaccine Adjuvants Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection. Adjuvants are substances added to vaccines to enhance the immunogenicity of highly purified antigens that have insufficient immunostimulatory capabilities, and have been used in human vaccines for more than 90 years. And many vaccines also contain an adjuvant or adjuvant combination: these are substances added to vaccines specifically because of their immune enhancing effects. Adjuvants were initially used to counter the poor immunogenic potential of highly purified antigens. In recent years their role has expanded as our understanding of the immunology of vaccination has grown.
According to APO Research, The global Vaccine Adjuvants market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Vaccine Adjuvants is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Vaccine Adjuvants include GSK, CSL Limited, Croda, SEPPIC, Novavax, SPI Pharma, Phibro, SDA BIO and Invivogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Adjuvants.
The Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GSK
- CSL Limited
- Croda
- SEPPIC
- Novavax
- SPI Pharma
- Phibro
- SDA BIO
- Invivogen
- Tj Kaiwei
- OZ Biosciences
- Brenntag Biosector
- MVP Laboratories
- Zhuoyue
- Aphios
- Aluminum Adjuvant
- Emulsions Adjuvant
- Others
- Human Vaccine
- Veterinary Vaccine
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Adjuvants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Vaccine Adjuvants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Adjuvants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccine Adjuvants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Vaccine Adjuvants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
1.3 Vaccine Adjuvants Market by Type
1.3.1 Aluminum Adjuvant
1.3.2 Emulsions Adjuvant
1.3.3 Others
1.4 Global Vaccine Adjuvants Market Size by Type
1.4.1 Global Vaccine Adjuvants Market Size Overview by Type (2019-2030)
1.4.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2019-2024)
1.4.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Vaccine Adjuvants Revenue (2019-2024)
3.2 Global Top Players by Vaccine Adjuvants Sales (2019-2024)
3.3 Global Top Players by Vaccine Adjuvants Price (2019-2024)
3.4 Global Vaccine Adjuvants Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccine Adjuvants Key Company Manufacturing Sites & Headquarters
3.6 Global Vaccine Adjuvants Company, Product Type & Application
3.7 Global Vaccine Adjuvants Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
3.8.3 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
4 VACCINE ADJUVANTS REGIONAL STATUS AND OUTLOOK
4.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Vaccine Adjuvants Historic Market Size by Region
4.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2019-2024)
4.2.2 Global Vaccine Adjuvants Sales in Value by Region (2019-2024)
4.2.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Vaccine Adjuvants Forecasted Market Size by Region
4.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2025-2030)
4.3.2 Global Vaccine Adjuvants Sales in Value by Region (2025-2030)
4.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 VACCINE ADJUVANTS BY APPLICATION
5.1 Vaccine Adjuvants Market by Application
5.1.1 Human Vaccine
5.1.2 Veterinary Vaccine
5.2 Global Vaccine Adjuvants Market Size by Application
5.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2019-2030)
5.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2019-2024)
5.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments
6.2 CSL Limited
6.2.1 CSL Limited Comapny Information
6.2.2 CSL Limited Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments
6.3 Croda
6.3.1 Croda Comapny Information
6.3.2 Croda Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments
6.4 SEPPIC
6.4.1 SEPPIC Comapny Information
6.4.2 SEPPIC Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments
6.5 Novavax
6.5.1 Novavax Comapny Information
6.5.2 Novavax Business Overview
6.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novavax Vaccine Adjuvants Product Portfolio
6.5.5 Novavax Recent Developments
6.6 SPI Pharma
6.6.1 SPI Pharma Comapny Information
6.6.2 SPI Pharma Business Overview
6.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.6.5 SPI Pharma Recent Developments
6.7 Phibro
6.7.1 Phibro Comapny Information
6.7.2 Phibro Business Overview
6.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Phibro Vaccine Adjuvants Product Portfolio
6.7.5 Phibro Recent Developments
6.8 SDA BIO
6.8.1 SDA BIO Comapny Information
6.8.2 SDA BIO Business Overview
6.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.8.5 SDA BIO Recent Developments
6.9 Invivogen
6.9.1 Invivogen Comapny Information
6.9.2 Invivogen Business Overview
6.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Invivogen Vaccine Adjuvants Product Portfolio
6.9.5 Invivogen Recent Developments
6.10 Tj Kaiwei
6.10.1 Tj Kaiwei Comapny Information
6.10.2 Tj Kaiwei Business Overview
6.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
6.10.5 Tj Kaiwei Recent Developments
6.11 OZ Biosciences
6.11.1 OZ Biosciences Comapny Information
6.11.2 OZ Biosciences Business Overview
6.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
6.11.5 OZ Biosciences Recent Developments
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Comapny Information
6.12.2 Brenntag Biosector Business Overview
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
6.12.5 Brenntag Biosector Recent Developments
6.13 MVP Laboratories
6.13.1 MVP Laboratories Comapny Information
6.13.2 MVP Laboratories Business Overview
6.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
6.13.5 MVP Laboratories Recent Developments
6.14 Zhuoyue
6.14.1 Zhuoyue Comapny Information
6.14.2 Zhuoyue Business Overview
6.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
6.14.5 Zhuoyue Recent Developments
6.15 Aphios
6.15.1 Aphios Comapny Information
6.15.2 Aphios Business Overview
6.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Aphios Vaccine Adjuvants Product Portfolio
6.15.5 Aphios Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Vaccine Adjuvants Sales by Country
7.1.1 North America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Vaccine Adjuvants Sales by Country (2019-2024)
7.1.3 North America Vaccine Adjuvants Sales Forecast by Country (2025-2030)
7.2 North America Vaccine Adjuvants Market Size by Country
7.2.1 North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Vaccine Adjuvants Market Size by Country (2019-2024)
7.2.3 North America Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Vaccine Adjuvants Sales by Country
8.1.1 Europe Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Vaccine Adjuvants Sales by Country (2019-2024)
8.1.3 Europe Vaccine Adjuvants Sales Forecast by Country (2025-2030)
8.2 Europe Vaccine Adjuvants Market Size by Country
8.2.1 Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Vaccine Adjuvants Market Size by Country (2019-2024)
8.2.3 Europe Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Vaccine Adjuvants Sales by Country
9.1.1 Asia-Pacific Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Vaccine Adjuvants Sales by Country (2019-2024)
9.1.3 Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Vaccine Adjuvants Market Size by Country
9.2.1 Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Vaccine Adjuvants Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Vaccine Adjuvants Sales by Country
10.1.1 Latin America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Vaccine Adjuvants Sales by Country (2019-2024)
10.1.3 Latin America Vaccine Adjuvants Sales Forecast by Country (2025-2030)
10.2 Latin America Vaccine Adjuvants Market Size by Country
10.2.1 Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Vaccine Adjuvants Market Size by Country (2019-2024)
10.2.3 Latin America Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Vaccine Adjuvants Sales by Country
11.1.1 Middle East and Africa Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2024)
11.1.3 Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Vaccine Adjuvants Market Size by Country
11.2.1 Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Vaccine Adjuvants Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Vaccine Adjuvants Value Chain Analysis
12.1.1 Vaccine Adjuvants Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Vaccine Adjuvants Production Mode & Process
12.2 Vaccine Adjuvants Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Vaccine Adjuvants Distributors
12.2.3 Vaccine Adjuvants Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Vaccine Adjuvants Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Vaccine Adjuvants Sales Estimates and Forecasts (2019-2030)
1.3 Vaccine Adjuvants Market by Type
1.3.1 Aluminum Adjuvant
1.3.2 Emulsions Adjuvant
1.3.3 Others
1.4 Global Vaccine Adjuvants Market Size by Type
1.4.1 Global Vaccine Adjuvants Market Size Overview by Type (2019-2030)
1.4.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2019-2024)
1.4.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Vaccine Adjuvants Industry Trends
2.2 Vaccine Adjuvants Industry Drivers
2.3 Vaccine Adjuvants Industry Opportunities and Challenges
2.4 Vaccine Adjuvants Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Vaccine Adjuvants Revenue (2019-2024)
3.2 Global Top Players by Vaccine Adjuvants Sales (2019-2024)
3.3 Global Top Players by Vaccine Adjuvants Price (2019-2024)
3.4 Global Vaccine Adjuvants Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Vaccine Adjuvants Key Company Manufacturing Sites & Headquarters
3.6 Global Vaccine Adjuvants Company, Product Type & Application
3.7 Global Vaccine Adjuvants Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Vaccine Adjuvants Market CR5 and HHI
3.8.2 Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
3.8.3 2023 Vaccine Adjuvants Tier 1, Tier 2, and Tier
4 VACCINE ADJUVANTS REGIONAL STATUS AND OUTLOOK
4.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Vaccine Adjuvants Historic Market Size by Region
4.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2019-2024)
4.2.2 Global Vaccine Adjuvants Sales in Value by Region (2019-2024)
4.2.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Vaccine Adjuvants Forecasted Market Size by Region
4.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2025-2030)
4.3.2 Global Vaccine Adjuvants Sales in Value by Region (2025-2030)
4.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 VACCINE ADJUVANTS BY APPLICATION
5.1 Vaccine Adjuvants Market by Application
5.1.1 Human Vaccine
5.1.2 Veterinary Vaccine
5.2 Global Vaccine Adjuvants Market Size by Application
5.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2019-2030)
5.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2019-2024)
5.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments
6.2 CSL Limited
6.2.1 CSL Limited Comapny Information
6.2.2 CSL Limited Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments
6.3 Croda
6.3.1 Croda Comapny Information
6.3.2 Croda Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments
6.4 SEPPIC
6.4.1 SEPPIC Comapny Information
6.4.2 SEPPIC Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments
6.5 Novavax
6.5.1 Novavax Comapny Information
6.5.2 Novavax Business Overview
6.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novavax Vaccine Adjuvants Product Portfolio
6.5.5 Novavax Recent Developments
6.6 SPI Pharma
6.6.1 SPI Pharma Comapny Information
6.6.2 SPI Pharma Business Overview
6.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.6.5 SPI Pharma Recent Developments
6.7 Phibro
6.7.1 Phibro Comapny Information
6.7.2 Phibro Business Overview
6.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Phibro Vaccine Adjuvants Product Portfolio
6.7.5 Phibro Recent Developments
6.8 SDA BIO
6.8.1 SDA BIO Comapny Information
6.8.2 SDA BIO Business Overview
6.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.8.5 SDA BIO Recent Developments
6.9 Invivogen
6.9.1 Invivogen Comapny Information
6.9.2 Invivogen Business Overview
6.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Invivogen Vaccine Adjuvants Product Portfolio
6.9.5 Invivogen Recent Developments
6.10 Tj Kaiwei
6.10.1 Tj Kaiwei Comapny Information
6.10.2 Tj Kaiwei Business Overview
6.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
6.10.5 Tj Kaiwei Recent Developments
6.11 OZ Biosciences
6.11.1 OZ Biosciences Comapny Information
6.11.2 OZ Biosciences Business Overview
6.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
6.11.5 OZ Biosciences Recent Developments
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Comapny Information
6.12.2 Brenntag Biosector Business Overview
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
6.12.5 Brenntag Biosector Recent Developments
6.13 MVP Laboratories
6.13.1 MVP Laboratories Comapny Information
6.13.2 MVP Laboratories Business Overview
6.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
6.13.5 MVP Laboratories Recent Developments
6.14 Zhuoyue
6.14.1 Zhuoyue Comapny Information
6.14.2 Zhuoyue Business Overview
6.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
6.14.5 Zhuoyue Recent Developments
6.15 Aphios
6.15.1 Aphios Comapny Information
6.15.2 Aphios Business Overview
6.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Aphios Vaccine Adjuvants Product Portfolio
6.15.5 Aphios Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Vaccine Adjuvants Sales by Country
7.1.1 North America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Vaccine Adjuvants Sales by Country (2019-2024)
7.1.3 North America Vaccine Adjuvants Sales Forecast by Country (2025-2030)
7.2 North America Vaccine Adjuvants Market Size by Country
7.2.1 North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Vaccine Adjuvants Market Size by Country (2019-2024)
7.2.3 North America Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Vaccine Adjuvants Sales by Country
8.1.1 Europe Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Vaccine Adjuvants Sales by Country (2019-2024)
8.1.3 Europe Vaccine Adjuvants Sales Forecast by Country (2025-2030)
8.2 Europe Vaccine Adjuvants Market Size by Country
8.2.1 Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Vaccine Adjuvants Market Size by Country (2019-2024)
8.2.3 Europe Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Vaccine Adjuvants Sales by Country
9.1.1 Asia-Pacific Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Vaccine Adjuvants Sales by Country (2019-2024)
9.1.3 Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Vaccine Adjuvants Market Size by Country
9.2.1 Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Vaccine Adjuvants Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Vaccine Adjuvants Sales by Country
10.1.1 Latin America Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Vaccine Adjuvants Sales by Country (2019-2024)
10.1.3 Latin America Vaccine Adjuvants Sales Forecast by Country (2025-2030)
10.2 Latin America Vaccine Adjuvants Market Size by Country
10.2.1 Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Vaccine Adjuvants Market Size by Country (2019-2024)
10.2.3 Latin America Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Vaccine Adjuvants Sales by Country
11.1.1 Middle East and Africa Vaccine Adjuvants Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2024)
11.1.3 Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Vaccine Adjuvants Market Size by Country
11.2.1 Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Vaccine Adjuvants Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Vaccine Adjuvants Value Chain Analysis
12.1.1 Vaccine Adjuvants Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Vaccine Adjuvants Production Mode & Process
12.2 Vaccine Adjuvants Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Vaccine Adjuvants Distributors
12.2.3 Vaccine Adjuvants Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Aluminum Adjuvant
Table 2. Major Company of Emulsions Adjuvant
Table 3. Major Company of Others
Table 4. Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 6. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Vaccine Adjuvants Sales Market Share in Value by Type (2019-2024)
Table 9. Global Vaccine Adjuvants Price by Type (2019-2024) & (USD/Kg)
Table 10. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 11. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Vaccine Adjuvants Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Vaccine Adjuvants Sales Market Share in Value by Type (2025-2030)
Table 14. Global Vaccine Adjuvants Price by Type (2025-2030) & (USD/Kg)
Table 15. North America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 16. North America Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 18. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 20. Asia-Pacific Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 22. Latin America Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 24. Middle East and Africa Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 25. Vaccine Adjuvants Industry Trends
Table 26. Vaccine Adjuvants Industry Drivers
Table 27. Vaccine Adjuvants Industry Opportunities and Challenges
Table 28. Vaccine Adjuvants Industry Restraints
Table 29. Global Vaccine Adjuvants Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Vaccine Adjuvants Revenue Market Share by Company (2019-2024)
Table 31. Global Vaccine Adjuvants Sales by Company (2019-2024) & (MT)
Table 32. Global Vaccine Adjuvants Sales Share by Company (2019-2024)
Table 33. Global Vaccine Adjuvants Market Price by Company (2019-2024) & (USD/Kg)
Table 34. Global Vaccine Adjuvants Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Vaccine Adjuvants Key Company Manufacturing Sites & Headquarters
Table 36. Global Vaccine Adjuvants Company, Product Type & Application
Table 37. Global Vaccine Adjuvants Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 42. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Vaccine Adjuvants Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Vaccine Adjuvants Sales Market Share in Value by Region (2019-2024)
Table 45. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 46. Global Vaccine Adjuvants Sales by Region (2025-2030) & (MT)
Table 47. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Vaccine Adjuvants Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Vaccine Adjuvants Sales Market Share in Value by Region (2025-2030)
Table 50. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2025-2030)
Table 51. Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 53. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Vaccine Adjuvants Sales Market Share in Value by Application (2019-2024)
Table 56. Global Vaccine Adjuvants Price by Application (2019-2024) & (USD/Kg)
Table 57. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 58. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Vaccine Adjuvants Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Vaccine Adjuvants Sales Market Share in Value by Application (2025-2030)
Table 61. Global Vaccine Adjuvants Price by Application (2025-2030) & (USD/Kg)
Table 62. North America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 63. North America Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 65. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 67. Asia-Pacific Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 69. Latin America Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 71. Middle East and Africa Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 72. GSK Company Information
Table 73. GSK Business Overview
Table 74. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 75. GSK Vaccine Adjuvants Product Portfolio
Table 76. GSK Recent Development
Table 77. CSL Limited Company Information
Table 78. CSL Limited Business Overview
Table 79. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 80. CSL Limited Vaccine Adjuvants Product Portfolio
Table 81. CSL Limited Recent Development
Table 82. Croda Company Information
Table 83. Croda Business Overview
Table 84. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 85. Croda Vaccine Adjuvants Product Portfolio
Table 86. Croda Recent Development
Table 87. SEPPIC Company Information
Table 88. SEPPIC Business Overview
Table 89. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 90. SEPPIC Vaccine Adjuvants Product Portfolio
Table 91. SEPPIC Recent Development
Table 92. Novavax Company Information
Table 93. Novavax Business Overview
Table 94. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 95. Novavax Vaccine Adjuvants Product Portfolio
Table 96. Novavax Recent Development
Table 97. SPI Pharma Company Information
Table 98. SPI Pharma Business Overview
Table 99. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 100. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 101. SPI Pharma Recent Development
Table 102. Phibro Company Information
Table 103. Phibro Business Overview
Table 104. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 105. Phibro Vaccine Adjuvants Product Portfolio
Table 106. Phibro Recent Development
Table 107. SDA BIO Company Information
Table 108. SDA BIO Business Overview
Table 109. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 110. SDA BIO Vaccine Adjuvants Product Portfolio
Table 111. SDA BIO Recent Development
Table 112. Invivogen Company Information
Table 113. Invivogen Business Overview
Table 114. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Invivogen Vaccine Adjuvants Product Portfolio
Table 116. Invivogen Recent Development
Table 117. Tj Kaiwei Company Information
Table 118. Tj Kaiwei Business Overview
Table 119. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 121. Tj Kaiwei Recent Development
Table 122. OZ Biosciences Company Information
Table 123. OZ Biosciences Business Overview
Table 124. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 126. OZ Biosciences Recent Development
Table 127. Brenntag Biosector Company Information
Table 128. Brenntag Biosector Business Overview
Table 129. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 131. Brenntag Biosector Recent Development
Table 132. MVP Laboratories Company Information
Table 133. MVP Laboratories Business Overview
Table 134. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 135. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 136. MVP Laboratories Recent Development
Table 137. Zhuoyue Company Information
Table 138. Zhuoyue Business Overview
Table 139. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 140. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 141. Zhuoyue Recent Development
Table 142. Aphios Company Information
Table 143. Aphios Business Overview
Table 144. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 145. Aphios Vaccine Adjuvants Product Portfolio
Table 146. Aphios Recent Development
Table 147. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 148. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 149. North America Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 150. North America Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 151. North America Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 152. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Vaccine Adjuvants Market Share by Country (2019-2024)
Table 155. North America Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 157. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 158. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 159. Europe Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 160. Europe Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 161. Europe Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 162. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Europe Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 164. Europe Vaccine Adjuvants Market Share by Country (2019-2024)
Table 165. Europe Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Europe Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 167. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 168. Asia-Pacific Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 169. Asia-Pacific Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 170. Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 171. Asia-Pacific Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 172. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Asia-Pacific Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 174. Asia-Pacific Vaccine Adjuvants Market Share by Country (2019-2024)
Table 175. Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Asia-Pacific Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 177. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 178. Latin America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 179. Latin America Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 180. Latin America Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 181. Latin America Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 182. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Latin America Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 184. Latin America Vaccine Adjuvants Market Share by Country (2019-2024)
Table 185. Latin America Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Latin America Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 187. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 188. Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 189. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 190. Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 191. Middle East and Africa Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 192. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Middle East and Africa Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 194. Middle East and Africa Vaccine Adjuvants Market Share by Country (2019-2024)
Table 195. Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Middle East and Africa Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Vaccine Adjuvants Distributors List
Table 200. Vaccine Adjuvants Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
Table 1. Major Company of Aluminum Adjuvant
Table 2. Major Company of Emulsions Adjuvant
Table 3. Major Company of Others
Table 4. Global Vaccine Adjuvants Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 6. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Vaccine Adjuvants Sales Market Share in Value by Type (2019-2024)
Table 9. Global Vaccine Adjuvants Price by Type (2019-2024) & (USD/Kg)
Table 10. Global Vaccine Adjuvants Sales by Type (2025-2030) & (MT)
Table 11. Global Vaccine Adjuvants Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Vaccine Adjuvants Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Vaccine Adjuvants Sales Market Share in Value by Type (2025-2030)
Table 14. Global Vaccine Adjuvants Price by Type (2025-2030) & (USD/Kg)
Table 15. North America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 16. North America Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 18. Europe Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 20. Asia-Pacific Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 22. Latin America Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Vaccine Adjuvants Sales by Type (2019-2024) & (MT)
Table 24. Middle East and Africa Vaccine Adjuvants Sales by Type (2019-2024) & (US$ Million)
Table 25. Vaccine Adjuvants Industry Trends
Table 26. Vaccine Adjuvants Industry Drivers
Table 27. Vaccine Adjuvants Industry Opportunities and Challenges
Table 28. Vaccine Adjuvants Industry Restraints
Table 29. Global Vaccine Adjuvants Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Vaccine Adjuvants Revenue Market Share by Company (2019-2024)
Table 31. Global Vaccine Adjuvants Sales by Company (2019-2024) & (MT)
Table 32. Global Vaccine Adjuvants Sales Share by Company (2019-2024)
Table 33. Global Vaccine Adjuvants Market Price by Company (2019-2024) & (USD/Kg)
Table 34. Global Vaccine Adjuvants Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Vaccine Adjuvants Key Company Manufacturing Sites & Headquarters
Table 36. Global Vaccine Adjuvants Company, Product Type & Application
Table 37. Global Vaccine Adjuvants Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Vaccine Adjuvants Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Vaccine Adjuvants Sales by Region (2019-2024) & (MT)
Table 42. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Vaccine Adjuvants Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Vaccine Adjuvants Sales Market Share in Value by Region (2019-2024)
Table 45. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 46. Global Vaccine Adjuvants Sales by Region (2025-2030) & (MT)
Table 47. Global Vaccine Adjuvants Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Vaccine Adjuvants Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Vaccine Adjuvants Sales Market Share in Value by Region (2025-2030)
Table 50. Global Vaccine Adjuvants Sales (MT), Value (US$ Million), Price (USD/Kg) and Gross Margin (2025-2030)
Table 51. Global Vaccine Adjuvants Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 53. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Vaccine Adjuvants Sales Market Share in Value by Application (2019-2024)
Table 56. Global Vaccine Adjuvants Price by Application (2019-2024) & (USD/Kg)
Table 57. Global Vaccine Adjuvants Sales by Application (2025-2030) & (MT)
Table 58. Global Vaccine Adjuvants Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Vaccine Adjuvants Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Vaccine Adjuvants Sales Market Share in Value by Application (2025-2030)
Table 61. Global Vaccine Adjuvants Price by Application (2025-2030) & (USD/Kg)
Table 62. North America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 63. North America Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 65. Europe Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 67. Asia-Pacific Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 69. Latin America Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Vaccine Adjuvants Sales by Application (2019-2024) & (MT)
Table 71. Middle East and Africa Vaccine Adjuvants Sales by Application (2019-2024) & (US$ Million)
Table 72. GSK Company Information
Table 73. GSK Business Overview
Table 74. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 75. GSK Vaccine Adjuvants Product Portfolio
Table 76. GSK Recent Development
Table 77. CSL Limited Company Information
Table 78. CSL Limited Business Overview
Table 79. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 80. CSL Limited Vaccine Adjuvants Product Portfolio
Table 81. CSL Limited Recent Development
Table 82. Croda Company Information
Table 83. Croda Business Overview
Table 84. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 85. Croda Vaccine Adjuvants Product Portfolio
Table 86. Croda Recent Development
Table 87. SEPPIC Company Information
Table 88. SEPPIC Business Overview
Table 89. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 90. SEPPIC Vaccine Adjuvants Product Portfolio
Table 91. SEPPIC Recent Development
Table 92. Novavax Company Information
Table 93. Novavax Business Overview
Table 94. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 95. Novavax Vaccine Adjuvants Product Portfolio
Table 96. Novavax Recent Development
Table 97. SPI Pharma Company Information
Table 98. SPI Pharma Business Overview
Table 99. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 100. SPI Pharma Vaccine Adjuvants Product Portfolio
Table 101. SPI Pharma Recent Development
Table 102. Phibro Company Information
Table 103. Phibro Business Overview
Table 104. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 105. Phibro Vaccine Adjuvants Product Portfolio
Table 106. Phibro Recent Development
Table 107. SDA BIO Company Information
Table 108. SDA BIO Business Overview
Table 109. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 110. SDA BIO Vaccine Adjuvants Product Portfolio
Table 111. SDA BIO Recent Development
Table 112. Invivogen Company Information
Table 113. Invivogen Business Overview
Table 114. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 115. Invivogen Vaccine Adjuvants Product Portfolio
Table 116. Invivogen Recent Development
Table 117. Tj Kaiwei Company Information
Table 118. Tj Kaiwei Business Overview
Table 119. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 120. Tj Kaiwei Vaccine Adjuvants Product Portfolio
Table 121. Tj Kaiwei Recent Development
Table 122. OZ Biosciences Company Information
Table 123. OZ Biosciences Business Overview
Table 124. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 125. OZ Biosciences Vaccine Adjuvants Product Portfolio
Table 126. OZ Biosciences Recent Development
Table 127. Brenntag Biosector Company Information
Table 128. Brenntag Biosector Business Overview
Table 129. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 130. Brenntag Biosector Vaccine Adjuvants Product Portfolio
Table 131. Brenntag Biosector Recent Development
Table 132. MVP Laboratories Company Information
Table 133. MVP Laboratories Business Overview
Table 134. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 135. MVP Laboratories Vaccine Adjuvants Product Portfolio
Table 136. MVP Laboratories Recent Development
Table 137. Zhuoyue Company Information
Table 138. Zhuoyue Business Overview
Table 139. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 140. Zhuoyue Vaccine Adjuvants Product Portfolio
Table 141. Zhuoyue Recent Development
Table 142. Aphios Company Information
Table 143. Aphios Business Overview
Table 144. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
Table 145. Aphios Vaccine Adjuvants Product Portfolio
Table 146. Aphios Recent Development
Table 147. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 148. North America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 149. North America Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 150. North America Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 151. North America Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 152. North America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Vaccine Adjuvants Market Share by Country (2019-2024)
Table 155. North America Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 157. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 158. Europe Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 159. Europe Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 160. Europe Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 161. Europe Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 162. Europe Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Europe Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 164. Europe Vaccine Adjuvants Market Share by Country (2019-2024)
Table 165. Europe Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Europe Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 167. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 168. Asia-Pacific Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 169. Asia-Pacific Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 170. Asia-Pacific Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 171. Asia-Pacific Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 172. Asia-Pacific Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Asia-Pacific Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 174. Asia-Pacific Vaccine Adjuvants Market Share by Country (2019-2024)
Table 175. Asia-Pacific Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Asia-Pacific Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 177. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 178. Latin America Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 179. Latin America Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 180. Latin America Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 181. Latin America Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 182. Latin America Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Latin America Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 184. Latin America Vaccine Adjuvants Market Share by Country (2019-2024)
Table 185. Latin America Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Latin America Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 187. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (MT): 2019 VS 2023 VS 2030
Table 188. Middle East and Africa Vaccine Adjuvants Sales by Country (2019-2024) & (MT)
Table 189. Middle East and Africa Vaccine Adjuvants Sales Market Share by Country (2019-2024)
Table 190. Middle East and Africa Vaccine Adjuvants Sales Forecast by Country (2025-2030) & (MT)
Table 191. Middle East and Africa Vaccine Adjuvants Sales Market Share Forecast by Country (2025-2030)
Table 192. Middle East and Africa Vaccine Adjuvants Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Middle East and Africa Vaccine Adjuvants Market Size by Country (2019-2024) & (US$ Million)
Table 194. Middle East and Africa Vaccine Adjuvants Market Share by Country (2019-2024)
Table 195. Middle East and Africa Vaccine Adjuvants Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Middle East and Africa Vaccine Adjuvants Market Share Forecast by Country (2025-2030)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Vaccine Adjuvants Distributors List
Table 200. Vaccine Adjuvants Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
LIST OF FIGURES
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Vaccine Adjuvants Sales (2019-2030) & (MT)
Figure 5. Product Picture of Aluminum Adjuvant
Figure 6. Global Aluminum Adjuvant Sales YoY Growth (2019-2030) & (MT)
Figure 7. Product Picture of Emulsions Adjuvant
Figure 8. Global Emulsions Adjuvant Sales YoY Growth (2019-2030) & (MT)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2019-2030) & (MT)
Figure 11. Global Vaccine Adjuvants Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Vaccine Adjuvants Market Share by Type 2023 VS 2030
Figure 13. North America Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 14. North America Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 15. Europe Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 16. Europe Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 19. Latin America Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Human Vaccine
Figure 26. Global Human Vaccine Sales YoY Growth (2019-2030) & (MT)
Figure 27. Product Picture of Veterinary Vaccine
Figure 28. Global Veterinary Vaccine Sales YoY Growth (2019-2030) & (MT)
Figure 29. Global Vaccine Adjuvants Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Vaccine Adjuvants Market Share by Application 2023 VS 2030
Figure 31. North America Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 32. North America Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 33. Europe Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 34. Europe Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 37. Latin America Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 41. North America Vaccine Adjuvants Sales by Country: 2019 VS 2023 VS 2030 (MT)
Figure 42. North America Vaccine Adjuvants Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Vaccine Adjuvants Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Vaccine Adjuvants Sales by Country: 2019 VS 2023 VS 2030 (MT)
Figure 46. Europe Vaccine Adjuvants Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Vaccine Adjuvants Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-P
Figure 1. Vaccine Adjuvants Product Picture
Figure 2. Global Vaccine Adjuvants Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Vaccine Adjuvants Market Size (2019-2030) & (US$ Million)
Figure 4. Global Vaccine Adjuvants Sales (2019-2030) & (MT)
Figure 5. Product Picture of Aluminum Adjuvant
Figure 6. Global Aluminum Adjuvant Sales YoY Growth (2019-2030) & (MT)
Figure 7. Product Picture of Emulsions Adjuvant
Figure 8. Global Emulsions Adjuvant Sales YoY Growth (2019-2030) & (MT)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2019-2030) & (MT)
Figure 11. Global Vaccine Adjuvants Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Vaccine Adjuvants Market Share by Type 2023 VS 2030
Figure 13. North America Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 14. North America Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 15. Europe Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 16. Europe Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 19. Latin America Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Vaccine Adjuvants Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Human Vaccine
Figure 26. Global Human Vaccine Sales YoY Growth (2019-2030) & (MT)
Figure 27. Product Picture of Veterinary Vaccine
Figure 28. Global Veterinary Vaccine Sales YoY Growth (2019-2030) & (MT)
Figure 29. Global Vaccine Adjuvants Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Vaccine Adjuvants Market Share by Application 2023 VS 2030
Figure 31. North America Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 32. North America Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 33. Europe Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 34. Europe Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 37. Latin America Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Vaccine Adjuvants Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Vaccine Adjuvants Sales Market Share in Value by Application in 2023
Figure 41. North America Vaccine Adjuvants Sales by Country: 2019 VS 2023 VS 2030 (MT)
Figure 42. North America Vaccine Adjuvants Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Vaccine Adjuvants Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Vaccine Adjuvants Sales by Country: 2019 VS 2023 VS 2030 (MT)
Figure 46. Europe Vaccine Adjuvants Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Vaccine Adjuvants Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Vaccine Adjuvants Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-P
